Trial Profile
Effects of ARBs on ambulatory blood pressure, glucose and lipid metabolism, and autonomic nerve function in hypertensive diabetic nephropathy patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Telmisartan (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- 19 Sep 2015 Status changed from recruiting to completed, as reported by University Hospital Medical Information Network - Japan record.
- 22 Dec 2009 Results were presented in Koketsuatsu.
- 03 Nov 2008 New trial record.